SFEE Statement on recent developments in the pharmaceutical sector
Athens, 15/11/2017 – SFEE remains committed to ensuring patient access in Greece to innovative medicines that offer therapeutic value, as well as the viability of its member companies and their right to operate in a predictable business environment.
The State and the pharmaceutical industry should be on the same side, with a genuine will to understand and cooperate with each other, in order to safeguard, now and in the future, the right of all patients in Greece to access the necessary treatments that scientific progress brings to them.
